Norway - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Norway Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 6.6% year on year. In 2019, the country was ranked number 248 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 11 Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 11.00
2018 11.00
2017 10.00
2016 11.00
2015 6.00
Download all data from 2005 to 2019

How does Norway rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
248 #248
Lebanon
11 2019 +175.0 % +1.9 % View data
248 #248
Norway
11 2019 +0.0 % +6.6 % View data
251 #251
Cuba
10 2019 -64.3 % +0.0 % View data
Compare all 359 countries

Go Top